Functional polymers as human therapeutic agents

被引:20
作者
Dhal, PK [1 ]
Huval, CC [1 ]
Holmes-Farley, SR [1 ]
机构
[1] Genzyme Corp, Drug Discovery & Dev, Waltham, MA 02451 USA
关键词
D O I
10.1021/ie040290i
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Polymeric pharmaceuticals are drugs whose active components are polymers, neither a drug carrier nor a prodrug. The underlying concept for this class of therapeutic agents is to use high molecular weight and functional characteristics of polymers to selectively recognize, sequester, and remove low molecular weight and macromolecular disease-causing species in the intestinal fluid. The high molecular weight nature of these polymeric drugs makes them systemically nonabsorbed, thus providing a number of advantages including long-term safety profiles over traditional small molecule drug products. This Article summarizes some of the most recent efforts for the discovery and development of sequestrant-based polymeric drugs. Examples include sequestration of low molecular weight species such as bile acids, phosphate, and iron ions as well as polyvalent interactions to bind toxins, viruses, and bacteria using functional polymers. Furthermore, use of polymeric surfactant for treating sickle cell anemia has been reviewed.
引用
收藏
页码:8593 / 8604
页数:12
相关论文
共 102 条
[1]   The impact of improved phosphorus control: use of sevelamer hydrochloride in patients with chronic renal failure [J].
Amin, N .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (02) :340-345
[2]  
BACONKURTZ C, 2001, Patent No. 6290946
[3]  
BADMAN DG, 2000, IRON CHELATORS NEW D
[4]   CLOSTRIDIUM-DIFFICILE - HISTORY OF ITS ROLE AS AN ENTERIC PATHOGEN AND THE CURRENT STATE OF KNOWLEDGE ABOUT THE ORGANISM [J].
BARTLETT, JG .
CLINICAL INFECTIOUS DISEASES, 1994, 18 :S265-S272
[5]   Colesevelam HCl: a non-systemic lipid-altering drug [J].
Bays, H ;
Dujovne, C .
EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (05) :779-790
[6]   Sepsis and evolution of the innate immune response [J].
Beutler, B ;
Poltorak, A .
CRITICAL CARE MEDICINE, 2001, 29 (07) :S2-S6
[7]   A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients [J].
Bleyer, AJ ;
Burke, SK ;
Dillon, M ;
Garrett, B ;
Kant, KS ;
Lynch, D ;
Rahman, SN ;
Schoenfeld, P ;
Teitelbaum, I ;
Zeig, S ;
Slatopolsky, E .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (04) :694-701
[8]   Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].
Block, GA ;
Hulbert-Shearon, TE ;
Levin, NW ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617
[9]   Multivalency: Strength in numbers [J].
Borman, S .
CHEMICAL & ENGINEERING NEWS, 2000, 78 (41) :48-53
[10]   Regulation of renal and lower gastrointestinal function: role in fluid and electrolyte balance [J].
Braun, EJ .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY, 2003, 136 (03) :499-505